- Home
- NXPI vs ZTS Comparison
NXPI vs ZTS Comparison
Compare NXPI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | ZTS |
|---|---|---|
| Founded | 2006 | 1952 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8B | 48.7B |
| IPO Year | 2007 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NXPI | ZTS |
|---|---|---|
| Price | $198.71 | $117.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $245.89 | $156.20 |
| AVG Volume (30 Days) | 2.1M | ★ 3.4M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.05% | 1.82% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | ★ 7.95 | 6.02 |
| Revenue | ★ $12,269,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $12.58 | $5.67 |
| Revenue Next Year | $10.20 | $4.85 |
| P/E Ratio | $24.85 | ★ $19.38 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $148.09 | $113.30 |
| 52 Week High | $256.36 | $172.23 |
Technical Indicators
Market Signals| Indicator | NXPI | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.46 | 43.68 |
| Support Level | $185.84 | $117.42 |
| Resistance Level | $233.32 | $130.52 |
| Average True Range (ATR) | 6.17 | 3.28 |
| MACD | 0.96 | -0.13 |
| Stochastic Oscillator | 52.79 | 48.63 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.